Recherche en direct
TopFind récupère les correspondances les plus récentes pour votre recherche.
Nous avons examiné 8 résultats en direct pour xeljanz et retenu les 3 options qui semblent les plus utiles à comparer en premier.
Les thèmes les plus forts dans cette sélection sont Pharmaceutical et Extended Release Tablets.
Source: Pfizer (Thailand) Ltd.
Description
XELJANZ XR is the extended-release formulation of tofacitinib, delivered in 11 mg tablets for once-daily dosing. It is indicated for the treatment of inflammatory conditions like rheumatoid arthritis and psoriatic arthritis where consistent medicine levels are required.
Idéal pour
Once Daily dosing, Long Term maintenance et Chronic inflammation management
Évaluation
Source: Pfizer (Thailand) Ltd.
Description
XELJANZ is a prescription medicine containing tofacitinib, a Janus kinase (JAK) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It is available as 5 mg film-coated tablets and is registered with the Thai FDA.
Idéal pour
Rheumatoid arthritis patients, Psoriatic arthritis, Hospital prescriptions et Official brand preference
Évaluation
Source: Pfizer Thailand
Description
Xeljanz is the innovator brand of tofacitinib registered in Thailand. It is available in 5 mg film-coated tablets and 11 mg extended-release (XR) formats for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis at major hospitals.
Idéal pour
Patients in Thailand, Innovator drug preference, Insured medical treatments et Hospital Based pharmacy users
Évaluation
| Comparer | XELJANZ XR | XELJANZ | Xeljanz (Tofacitinib) |
|---|---|---|---|
| Source | Pfizer (Thailand) Ltd. | Pfizer (Thailand) Ltd. | Pfizer Thailand |
| Description | XELJANZ XR is the extended-release formulation of tofacitinib, delivered in 11 mg tablets for once-daily dosing. It is indicated for the treatment of inflammatory conditions like rheumatoid arthritis and psoriatic arthritis where consistent medicine levels are required. | XELJANZ is a prescription medicine containing tofacitinib, a Janus kinase (JAK) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It is available as 5 mg film-coated tablets and is registered with the Thai FDA. | Xeljanz is the innovator brand of tofacitinib registered in Thailand. It is available in 5 mg film-coated tablets and 11 mg extended-release (XR) formats for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis at major hospitals. |
| Idéal pour | Once Daily dosing, Long Term maintenance et Chronic inflammation management | Rheumatoid arthritis patients, Psoriatic arthritis, Hospital prescriptions et Official brand preference | Patients in Thailand, Innovator drug preference, Insured medical treatments et Hospital Based pharmacy users |
| Action | |||
| Évaluation |
Si vous voulez commencer par l'option la plus équilibrée, je vous recommande :
"XELJANZ XR de Pfizer (Thailand) Ltd.."
Je l'ai choisi parce que Offers the convenience of once-daily dosing through its extended-release formulation, supported by Pfizer's official clinical standards.